Hematopoietic cells are continuously generated throughout life from hematopoietic stem cells, thus making hematopoiesis a favorable system to study developmental cell lineage commitment. The main factors incorporating environmental signals to developing hematopoietic cells are cytokines, which regulate commitment of hematopoietic progenitors to the different blood lineages by acting either in an instructive or a permissive manner. Flt3-ligand (FL) and Interleukin-7 (IL7) are cytokines pivotal for B cell development, as manifested by the severely compromised B cell development in their absence. However, their precise role in regulating B cell commitment has been the subject of debate. In the present study we assessed the rescue of B cell commitment in mice lacking IL7 but simultaneously over-expressing FL. Results obtained demonstrate that FL over-expression in IL7 deficient mice rescues B cell commitment, resulting in significant Ebf1 and Pax5 expression in Ly6D + CD135 + CD127 + CD19precursors and subsequent generation of normal numbers of CD19 + B cell progenitors, therefore indicating that IL7 can be dispensable for commitment to the B cell lineage. Further analysis of Ly6D + CD135 + CD127 + CD19progenitors in IL7-or FL-deficient mice overexpressing Bcl2, as well as in IL7-transgenic mice suggests that both FL and IL7 regulate B cell commitment in a permissive manner; FL by inducing proliferation of CD135 + CD127 + Ly6D + CD19progenitors and IL7 by providing survival signals to these progenitors. 3 SIGNIFICANCE STATEMENT The generation of different blood lineages is regulated by hematopoietic cytokines, either in an instructive or in a permissive manner. The cytokines Interleukin-7 and Flt3-ligand are required for B cell development but their precise mode of action remains controversial. Our study has addressed the role of these cytokines in B cell commitment by analyzing the progenitor stage where B cell commitment occurs in mice over-expressing one of the two cytokines in the absence of the other. Our results demonstrate a permissive role for both cytokines in B cell commitment. Interleukin-7 promotes survival of progenitors instead of up-regulation of B cell commitment factors Ebf1 and Pax5, as previously hypothesized, whereas Flt3-ligand facilitates progenitor expansion by inducing their proliferation. \body 4
SIGNIFICANCE STATEMENT
The generation of different blood lineages is regulated by hematopoietic cytokines, either in an instructive or in a permissive manner. The cytokines Interleukin-7 and so by acting either in an instructive or a permissive manner (1) . In the instructive model, cytokines induce a signaling cascade in progenitors leading to the initiation of a lineage-specific gene program, typically through up-regulation and/or activation of transcription factors, eventually resulting in commitment to a particular lineage. In contrast, the permissive model advocates that commitment of progenitors to different lineages occurs in a cell-autonomous, stochastic manner, with cytokines acting as a selection rather than a commitment factor, promoting the survival and/or proliferation of a specific lineage at the expense of other lineages originating from the same progenitor. Elucidating the precise mode of action of cytokines is technically challenging and therefore the instructive versus permissive roles of cytokines is hotly debated (2) (3) (4) . Although the permissive model was favored in the past, recent data provide solid evidence for the instructive action of several cytokines including M-CSF, G-CSF, EPO and Flt3-ligand (5) (6) (7) (8) . However, our understanding of how cytokines regulate hematopoiesis remains elusive, as different cytokines can act in various ways and their function might be cell-context dependent (9) . Moreover, most studies to date have addressed cytokine regulated myeloid differentiation with relatively little information on lymphoid lineage commitment.
That Interleukin-7 (IL7) is a crucial cytokine for B cell generation is demonstrated by the dramatic defect in B cell generation in mice lacking either the cytokine (10) or its receptor (11) . Interestingly, while human B cell progenitors are also responsive to IL7 (12), disruption of IL7 signaling caused by mutations does not ablate B cell development in man (13, 14) . IL7 was initially identified as a growth factor for B cell progenitors (15) and early studies demonstrated that in vivo overexpression of the pro-survival gene Bcl2 did not rescue B cell development in the absence of IL7 signaling suggesting that IL7 acts in an instructive manner in B cell commitment (16, 17) . The subsequent findings that uncommitted Common Lymphoid Progenitors (CLP) from Il7 -/mice lacked expression of the transcription factor Early B-cell Factor 1 (Ebf1) (18) and that Ebf1 over-expression partially restored B cell generation from these CLP (19) , led to the hypothesis that IL7, through Stat5 activation, instructs commitment to the B cell lineage by initiating Ebf1 expression in uncommitted progenitors. Supporting this hypothesis, a putative Stat5 binding site was later identified in one of the Ebf1 promoters (20) . However, a more recent study has shown that Bcl2 can rescue B cell generation in a Stat5 conditional knock-out mouse (21) . Furthermore, the Ebf1-expressing fraction of CLP (Ly6D + CLP) is dramatically reduced in Il7 -/mice (22) , therefore providing an alternative possibility for the reduced Ebf1 expression observed in Il7 -/-CLP. Interestingly, B cell lineage commitment is initiated at the molecular level in Ly6D + CD19progenitors (23) .
Hence, while the importance of IL7 as a growth factor for committed B cell progenitors has been well established, it remains unclear whether it instructs oligo-potent progenitors to commit to the B cell lineage through Ebf1 and Pax5 upregulation.
Ftl3-ligand (FL), the only known ligand for the Flt3 receptor (CD135), is a cytokine important for the generation of many hematopoietic lineages and its function has gained much attention as mutations in FL signaling are commonly found in Acute Myeloid Leukemias (AML) (24) . Committed B cell progenitors do not express CD135 since expression of the B cell commitment factor Pax5 leads to its downregulation (25) . However, upon transplantation, bone marrow progenitors from Flt3 -/and Flt3l -/mice reconstitute the B cell compartment poorly (26, 27) , and FL was found to be essential for maintaining normal numbers of uncommitted B cell progenitors (28) .
Recently, we described a FL-transgenic mouse model (hereafter Flt3ltg)
expressing high levels of FL in vivo, which has enabled us to suggest an instructive role for FL in early stages of hematopoiesis (8) . By breeding these mice with Il7 -/mice we herein show that increased FL levels can rescue B cell commitment in 
RESULTS

Increased in vivo levels of FL rescue B cell commitment in Il7 -/-Ly6D + CD19 -
progenitors.
We have previously characterized an uncommitted B cell progenitor with combined lymphoid and myeloid potential (Early Progenitor with Lymphoid and Myeloid potential -EPLM) (29) . EPLM can be further subdivided by SiglecH, CD11c, CD115
and Ly6D expression enabling us to identify the Ly6D + SiglecH -CD11c -CD115fraction of EPLM (hereafter Ly6D + EPLM) as the population containing most B cell potential, while being devoid of myeloid potential ( Fig. S1B ). This EPLM subpopulation is identified as Lin -CD19 -CD117 int B220 int Ly6D + CD135 + CD127 + ( Figure 1A ) therefore partially overlapping phenotypically with Ly6D + CLP ( Fig.   S1A ) and pre-pro-B cells (30, 31) . Ly6D + EPLM numbers in Il7 -/and Flt3l -/mice are significantly decreased compared to WT; 7-fold for Il7 -/and 13-fold for Flt3l -/respectively and a similar dramatic decrease was observed in Ly6D + CLP from both mutant mice ( Figure 1B We have recently generated a mouse model expressing high in vivo levels of FL (8) . The progenitor compartment of these mice showed a dramatic increase in EPLM and CLP numbers, with their Ly6D + fractions increased 90-fold and 28-fold respectively relative to WT ( Figure 1D -E). We crossed Flt3ltg with Il7 -/mice to assess the extent to which increased FL levels could potentially rescue the loss of Ly6D + CD19progenitors in Il7 -/mice. As shown in Figure 2 A-B, in vivo overexpression of FL leads to a significant increase in Flt3ltg-Il7 -/-EPLM and CLP numbers, reaching levels of those in Flt3ltg mice. Crucially, a full rescue of Ly6D + EPLM and CLP can be seen in these mice, with a striking 470-fold and 31-fold increase in numbers compared to their Il7 -/counterparts (Figure 2A-B ). Furthermore, the numbers of the earliest committed CD19 + CD117 + pro-B cells were fully restored in Flt3ltg-Il7 -/mice, showing a 251-fold increase compared to Il7 -/-( Figure 2C and Flt3ltg-Il7 -/mice ( Fig S3) , a significant increase in splenic T cell numbers was observed ( Fig. S4 ) as a result of their expansion upon FL over-expression (32) .
To assess whether these rescued Flt3ltg-Il7 -/-Ly6D + CD19progenitors could give rise to B cells in vitro, we sorted Flt3ltg-Il7 -/-Ly6D + EPLM and plated them at limiting dilution on OP9 stromal cells in the presence of IL7. As shown in Figure 3A ,
Flt3ltg-Il7 -/-Ly6D + EPLM could generate B cells at similar frequencies to their WT and Flt3ltg counterparts, whereas the few Il7 -/-Ly6D + EPLM isolated could not. A rescue in Ly6D + EPLM was also observed when Il7 -/mice were injected with FL ( Figure 3E ) and when plated under the same conditions these rescued Ly6D + EPLM also showed a restored in vitro B cell potential ( Fig. S5A ). Further, when transplanted into irradiated Rag2 -/mice they were able to generate IgM + B cells ( Fig S5B-C) .
Thus, increased FL levels restore the generation of Ly6D + progenitors, rather than merely expanding the few Ly6D + EPLM/CLP found in Il7 -/mice. Real-time quantitative PCR analysis of Ly6D + EPLM from Flt3ltg-Il7 -/mice revealed significant expression of Ebf1, Pax5 and Foxo1 transcription factors' mRNA in the absence of IL7 ( Figure 3B ). Ebf1 expression at the protein level was confirmed by intracellular FACS staining ( Figure 3C -D). Even though the percentage of Flt3ltg-Il7 -/-Ebf1 + Ly6D + EPLM did not reach WT levels, it was similar to the one found in Even though our Flt3ltg-Il7 -/mouse model suggests that IL7 is dispensable for B cell commitment, the dramatic decrease in Il7 -/-Ly6D + EPLM/CLP argues for a role of IL7 in the maintenance of this population when FL levels are limiting, by promoting either their survival or their proliferation. To investigate the potential role of IL7 as a survival factor for Ly6D + CD135 + CD127 + CD19progenitors, we crossed Il7 -/mice with mice expressing the pro-survival gene Bcl2 (35) . Bcl2tg-Il7 -/mice demonstrated a minor but statistically significant 2.6-fold increase in Ly6D + EPLM and 2.2-fold increase in Ly6D + CLP numbers compared to Il7 -/mice ( Figure 4A-B ). Cell cycle stage analysis of Ly6D + EPLM of these mice indicated that most of the cells rescued by Bcl2 are in a quiescent state ( Fig. S6 ) and do not proliferate in response to cytokines, thereby compromising to some extent the rescue of these progenitors' numbers. Importantly, when plated on OP9 stromal cells plus IL7, Bcl2tg-Il7 -/-Ly6D + EPLM generated B cells at frequencies similar to WT mice ( Figure 4C ), indicating that these rescued Ly6D + cells had B cell potential. Indeed, when analyzing bone marrow CD19 + committed progenitors, we could see a significant 68-fold increase in the earliest CD19 + CD117 + pro-B cell compartment, compared to Il7 -/-( Figure 4D ).
Due to the their quiescent state {Fig. S6 and (36)} and the IL7 dependence of their proliferation, Bcl2tg-Il7 -/-CD19 + CD117 + numbers did not reach WT levels, whereas downstream CD19 + immature B cells showed a less pronounced, but significant rescue ( Figure 4D ). In the periphery of these mice, marginal zone and follicular B cell numbers were increased, whereas as previously reported (16) To evaluate the potential proliferative effect of IL7 on Ly6D + CD135 + CD127 + CD19progenitors, we analyzed a transgenic mouse model in which Il7 expression is driven by an MHC Class II promoter, resulting in increased in vivo levels of IL7 (37) . These mice exhibit a lymphoproliferative phenotype with increased numbers of CD19 + B cells (38) . In contrast to bone marrow CD19 + cells, Ly6D + EPLM numbers did not increase in response to elevated IL7 ( Figure 5A-C ). In addition, the cell cycle profile of Ly6D + EPLM remained unaltered in Il7tg mice compared to WT ( Figure 5D ), arguing against a proliferative action of IL7 on these progenitors. To exclude the possibility that a proliferative signal by FL present in these mice compromised the effect of increased IL7 on the cell cycle status of Ly6D + EPLM, we crossed Il7tg with Flt3l -/mice. Over-expression of IL7 in vivo did not result in a significant increase in Ly6D + EPLM or CLP numbers in the absence of FL ( Figure 5E and FigS8) . In contrast, a 3-fold increase in CD19 + CD117 + numbers was observed ( Figure 5F ), in agreement with the proliferative effect of IL7 on CD19 + B cells. This resulted in a small, but significant, increase in splenic follicular B cells ( Fig. S9 ). Moreover, cell cycle analysis of Il7tg-Flt3l -/-Ly6D + EPLM showed no significant change in their cycling profile compared to their Flt3l -/counterparts ( Figure 5G ). Therefore, we conclude that while IL7 acts as a proliferative factor for CD19 + committed B cells, it does not do so for their Ly6D + CD135 + CD127 + CD19precursors.
FL induces proliferation of Ly6D + CD135 + CD127 + CD19progenitors.
As evident in Figure 5G , loss of in vivo FL signaling affected the proliferative status of Ly6D + EPLM. Comparison of Ly6D + EPLM numbers in mice either lacking or over-expressing FL showed a 14-fold reduction in Flt3l -/-Ly6D + EPLM numbers compared to WT, while Flt3ltg Ly6D + EPLM increased 105-fold ( Figure 6A ). A similar response to FL levels was observed for Ly6D + CLP ( Figure 6A ). Cell cycle analysis of Ly6D + EPLM from these mice showed a significant increase in the percentage of Ki67 -DAPIcells and a decrease in the percentage of Ki67 + cells when FL signaling was absent, while Flt3ltg Ly6D + EPLM showed the reverse ( Figure 6B and Fig. S10 ). Thus, our data indicate that FL promotes the proliferation of
To evaluate if FL also regulates the survival of Ly6D + CD135 + CD127 + CD19progenitors, we crossed Flt3l -/mice with Bcl2tg mice. Thus, Bcl2tg-Flt3l -/mice showed a minor 2-fold increase in Ly6D + EPLM numbers compared to their Flt3l -/counterparts (1.8-fold for Ly6D + CLP) ( Figure 6C ). Nevertheless, the in vitro B cell potential of Flt3l -/-Ly6D + EPLM progenitors was not improved by Bcl2 overexpression ( Figure 6D ). Downstream CD19 + progenitors also demonstrated a partial, but significant, rescue ( Figure 6E ). Our analysis of Bcl2tg-Flt3l -/mice suggests that 
FL does not instruct commitment to the B cell lineage.
The striking rescue in B cell commitment observed in our Flt3ltg-Il7 -/mice could be explained by a potential instructive role of FL when present at high levels in vivo.
However, increased FL did not result in Ebf1 or Pax5 up-regulation ( Figure 3B-D) .
Moreover, analysis of Flt3l -/-Ly6D + EPLM showed that while absence of FL in vivo leads to a reduction in the numbers of Ly6D + EPLM ( Figure 1C ), it does not significantly reduce the percentage of Ebf1 + cells within the population ( Figure 7A-B ), consistent with a permissive rather than instructive role of FL. Finally, the decrease in the Ebf1 + fraction of Ly6D + EPLM upon exposure to high levels of FL was reflected in the increased ability of these progenitors to give rise to T cells in vitro, as manifested by the high frequency of T cell clone generation when Flt3ltg
Ly6D + EPLM were plated on OP9DL1 stromal cells in the presence of IL7 ( Figure   7C ). The above data suggest that FL does not instruct commitment to the B cell lineage through up-regulation of Ebf1 and Pax5 expression.
DISCUSSION
Commitment to the B cell lineage is mediated by the expression of Ebf1 and Pax5
transcription factors and it is initiated in CD135 + CD127 + Ly6D + progenitors prior to CD19 expression (30, 31) . In Il7 -/mice, this Ly6D + CLP compartment is significantly reduced (22) , a finding confirmed in the present study for both CLP and EPLM, a B220 int/+ population partly overlapping with CLP and pre-pro B cells ( Figure 1B up-regulation at the Ly6D + CD19stage (Figures 2 and 3) . These results suggest that
IL7 is not acting as an instructive cytokine in B cell commitment by initiating Ebf1
and Pax5 expression at the CD135 + CD127 + CD19stage, as previously hypothesized (18) (19) (20) , but rather as a permissive one.
Early investigations had shown that Bcl2 over-expression in the absence of IL7 signaling could rescue T cell (39, 40) but not B cell development (16, 17) .
However, a more recent study demonstrated a Bcl2-mediated rescue of CD19 + progenitors in conditional Stat5 -/mice, as well as a strong activation of the prosurvival gene Mcl1 expression by Stat5 (21), therefore suggesting a survival role for IL7 in B cell development. Our use of Il7 -/mice instead of Il7rα -/-, which allows the assessment of progenitor in vitro B cell potential, and our focus on Ly6D + CD135 + CD127 + CD19progenitors, has enabled us to confirm the latter findings and extend them to the CD19stage where B cell commitment events are initiated at the molecular level. Interestingly, Il7tg mice analysis showed that IL7 indeed acts as a proliferative factor for committed CD19 + cells, but not for their CD19precursors. Even in the absence of FL, excess IL7 was unable to significantly increase Ly6D + CLP/EPLM numbers, while it did so for CD19 + B cell progenitors ( Figure 5 ). Hence, we propose that the main role of IL7 at the CD135 + CD127 + CD19stage is to provide survival signals to the progenitors until they commit to the B cell lineage upon Pax5 and CD19 expression, after which it additionally induces their proliferation ( Figure 7D ). This survival role becomes particularly critical when FL levels are limiting, thereby explaining the reduction in Ly6D + CLP/EPLM seen in Il7 -/mice. Our study, in agreement with previous data (21) , identifies a common, permissive rather than instructive role for IL7 in both B and T cell development (39, 40) . signaling pathway (13, 14) . However, all patients with such mutations are neonates and in neonatal Il7 -/mice, B cell development also takes place (43) . Therefore, the apparent difference in the IL7 dependency of B cell development between man and mouse could actually reflect the corresponding difference between fetal/neonatal and adult lymphopoiesis. Our data showing that increased FL signaling can rescue B cell commitment in the absence of IL7 could provide a potential explanation for this difference. Fetal/neonatal CD135 + CD127 + CD19progenitors might be exposed to higher levels of FL and/or show higher sensitivity to FL signaling than adult CD135 + CD127 + CD19progenitors. Indeed, previous studies showed that despite a preferable response of fetal B cell progenitors to TSLP, FL signaling remains an absolute requirement for fetal B lymphopoiesis (44, 45).
The instructive or permissive progenitor regulation of lineage commitment by cytokines is a complex process, in which cytokines can initiate developmental transcription programs in progenitors. However, the reverse is also true, since the particular epigenetic, transcriptional and signaling landscape of a cell can affect its response to a cytokine (9) . Indeed, while previous analysis of 
MATERIALS AND METHODS
Mice.
For breeding and analysis, age-and sex-matched C57BL/6 Flt3l -/- (27) , Flt3ltg (8), 
In vitro limiting dilution assays.
Experiments have been performed as previously described (47). Briefly, OP9 or OP9DL1 stromal cells were plated on flat-bottom 96-well plates one day before the initiation of co-cultures, at a concentration of 3000 cells per well. The following day stromal cells were γ-irradiated (3000 rad) and the sorted progenitor cells were added at different concentrations. Cultures were maintained in IMDM medium supplemented with 5 × 10 -5 M β-mercaptoethanol, 1 mM glutamine, 0.03% (wt/vol) primatone, 100 U/mL penicillin, 100 μg/mL streptomycin, 5% FBS and 10% IL7conditioned medium. After 14 days in culture all wells were inspected under an inverted microscope and wells containing colonies of more than 50 cells were scored as positive.
Quantitative real-time PCR.
RNA extraction was performed using TRI Reagent® (Life Technologies) followed by cDNA synthesis using using GoScript™ Reverse Transcriptase (Promega). Real-time PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems).
Statistical analysis.
Statistical analysis was performed with Prism 6.0g software (GraphPad Software, 
